Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05976165 · ClinicalTrials.gov registry record · NA

A Study of Breath Testing for Small Intestinal Bacterial Overgrowth

A NA study of Gastroesophageal Reflux and Heartburn, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05976165 is a NA study of Gastroesophageal Reflux and Heartburn that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 183-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05976165, a NA study of Gastroesophageal Reflux and Heartburn, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.

Interventions

  • OTHER Breath Testing

Study Locations (1)

Florida

  • Mayo Clinic Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-11-17
Est. Completion 2027-01-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05976165

The ClinicalTrials.gov registry entry for NCT05976165 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (73% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 1 intervention - of which Breath Testing is the first listed.

NCT05976165 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05976165 about?

NCT05976165 is a clinical study titled "A Study of Breath Testing for Small Intestinal Bacterial Overgrowth". Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.

What is the current status of trial NCT05976165?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-11-17. Estimated completion is 2027-01-31.

What conditions does trial NCT05976165 study?

This clinical trial studies the following conditions: Gastroesophageal Reflux, Heartburn, Regurgitation.

What interventions are being tested in trial NCT05976165?

The interventions under investigation include: Breath Testing (OTHER).

Who is sponsoring clinical trial NCT05976165?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05976165 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroesophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.